{"entity":{"type":"insider","cik":"0001923794","url":"/insider/0001923794","json_url":"/insider/0001923794.json","name":"Tyagarajan Seshu","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2022-12-12","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Tyagarajan Seshu","source":"filing","n_filings":10,"first_seen":"2022-12-12","last_seen":"2026-08-19"}],"transactions":[{"id":9298299,"accession":"0001923794-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001923794-26-000004","line_url":"/filing/0001923794-26-000004#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":84000.0,"total_display":"84,000.00","total_whole":"84,000","shares_owned_after":76865.0,"shares_owned_after_display":"76,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":5759760,"accession":"0001923794-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001923794-26-000002","line_url":"/filing/0001923794-26-000002#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":10.0216,"price_display":"10.02","price_state":"stated","total_value":70151.2,"total_display":"70,151.20","total_whole":"70,151","shares_owned_after":83865.0,"shares_owned_after_display":"83,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":9213133,"accession":"0000950170-25-042724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-042724","line_url":"/filing/0000950170-25-042724#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31278.0,"shares_display":"31,278","price_per_share":8.8224,"price_display":"8.82","price_state":"stated","total_value":275947.0272,"total_display":"275,947.03","total_whole":"275,947","shares_owned_after":85512.0,"shares_owned_after_display":"85,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-20","scope":"insider"},{"id":4910767,"accession":"0000950170-25-042002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-042002","line_url":"/filing/0000950170-25-042002#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31278.0,"shares_display":"31,278","price_per_share":8.8224,"price_display":"8.82","price_state":"stated","total_value":275947.0272,"total_display":"275,947.03","total_whole":"275,947","shares_owned_after":85512.0,"shares_owned_after_display":"85,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":4614444,"accession":"0000950170-25-006733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006733","line_url":"/filing/0000950170-25-006733#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14322.0,"shares_display":"14,322","price_per_share":7.225,"price_display":"7.22","price_state":"stated","total_value":103476.45,"total_display":"103,476.45","total_whole":"103,476","shares_owned_after":96790.0,"shares_owned_after_display":"96,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":5029572,"accession":"0000950170-25-004197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-004197","line_url":"/filing/0000950170-25-004197#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14545.0,"shares_display":"14,545","price_per_share":8.2182,"price_display":"8.22","price_state":"stated","total_value":119533.719,"total_display":"119,533.72","total_whole":"119,534","shares_owned_after":111112.0,"shares_owned_after_display":"111,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":2243294,"accession":"0000950170-24-132932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-132932","line_url":"/filing/0000950170-24-132932#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20392.0,"shares_display":"20,392","price_per_share":4.5556,"price_display":"4.56","price_state":"stated","total_value":92897.7952,"total_display":"92,897.80","total_whole":"92,898","shares_owned_after":125657.0,"shares_owned_after_display":"125,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2896026,"accession":"0000950170-24-084762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084762","line_url":"/filing/0000950170-24-084762#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14851.0,"shares_display":"14,851","price_per_share":6.4726,"price_display":"6.47","price_state":"stated","total_value":96124.5826,"total_display":"96,124.58","total_whole":"96,125","shares_owned_after":146049.0,"shares_owned_after_display":"146,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":2305224,"accession":"0000950170-24-083403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-083403","line_url":"/filing/0000950170-24-083403#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13330.0,"shares_display":"13,330","price_per_share":5.9734,"price_display":"5.97","price_state":"stated","total_value":79625.422,"total_display":"79,625.42","total_whole":"79,625","shares_owned_after":160900.0,"shares_owned_after_display":"160,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-15","scope":"insider"},{"id":6673872,"accession":"0001209191-22-060692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060692","line_url":"/filing/0001209191-22-060692#line-2","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10358.0,"shares_display":"10,358","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":19990.94,"total_display":"19,990.94","total_whole":"19,991","shares_owned_after":13358.0,"shares_owned_after_display":"13,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-12","scope":"insider"},{"id":6673869,"accession":"0001209191-22-060692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060692","line_url":"/filing/0001209191-22-060692#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001923794","owner_name":"Tyagarajan Seshu","owner_display_name":"Tyagarajan Seshu","owner_url":"/insider/0001923794","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":5070.0,"total_display":"5,070.00","total_whole":"5,070","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001841387","name":"Candel Therapeutics, Inc.","url":"/issuer/0001841387","role":"Officer (Chief Technology Officer)","n_filings":10,"first_seen":"2022-12-12","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001923794","retrieved_at":"2026-08-27T04:10:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}